Detalhe da pesquisa
1.
Immunohistochemical loss of enhancer of Zeste Homolog 2 (EZH2) protein expression correlates with EZH2 alterations and portends a worse outcome in myelodysplastic syndromes.
Mod Pathol
; 35(9): 1212-1219, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35504958
2.
Improved outcomes among newly diagnosed patients with FMS-like tyrosine kinase 3 internal tandem duplication mutated acute myeloid leukemia treated with contemporary therapy: Revisiting the European LeukemiaNet adverse risk classification.
Am J Hematol
; 97(3): 329-337, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34981570
3.
The survival impact of CKS1B gains or amplification is dependent on the background karyotype and TP53 deletion status in patients with myeloma.
Mod Pathol
; 34(2): 327-335, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32908255
4.
B-cell lymphomas associated with breast implants: Report of three cases and review of the literature.
Ann Diagn Pathol
; 46: 151512, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32315816
5.
CD123 expression patterns and selective targeting with a CD123-targeted antibody-drug conjugate (IMGN632) in acute lymphoblastic leukemia.
Haematologica
; 104(4): 749-755, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30361418
6.
Secondary Philadelphia chromosome acquired during therapy of acute leukemia and myelodysplastic syndrome.
Mod Pathol
; 31(7): 1141-1154, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29449681
7.
P53 protein overexpression in de novo acute myeloid leukemia patients with normal diploid karyotype correlates with FLT3 internal tandem duplication and worse relapse-free survival.
Am J Hematol
; 93(11): 1376-1383, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30117185
8.
Clinical implications of cytogenetic heterogeneity in multiple myeloma patients with TP53 deletion.
Mod Pathol
; 30(10): 1378-1386, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28664940
9.
Malignancy-associated hemophagocytic lymphohistiocytosis in adults: Relation to hemophagocytosis, characteristics, and outcomes.
Cancer
; 122(18): 2857-66, 2016 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27244347
10.
MYC/BCL6 double-hit lymphoma (DHL): a tumour associated with an aggressive clinical course and poor prognosis.
Histopathology
; 68(7): 1090-8, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26426741
11.
Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis in vitro.
Biochem Pharmacol
; 220: 115981, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38081370
12.
Phenotypic evolution in a case of peripheral T-cell lymphoma suggests the presence of tumor heterogeneity.
J Cutan Pathol
; 40(6): 573-9, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23495765
13.
Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis.
Res Sq
; 2023 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37162954
14.
Acute promyelocytic leukemia: Immunophenotype and differential diagnosis by flow cytometry.
Cytometry B Clin Cytom
; 102(4): 283-291, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35716019
15.
Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia.
Signal Transduct Target Ther
; 7(1): 51, 2022 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35185150
16.
De novo acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2): a clinicopathologic and cytogenetic study of an entity recently added to the WHO classification.
Mod Pathol
; 24(3): 384-9, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21113141
17.
Autoimmune cytopenias in patients with chronic lymphocytic leukemia treated with ibrutinib.
Haematologica
; 101(6): e254-8, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27013651
18.
Synchronous del5q myelodysplastic syndrome (del5qMDS) and adult B-cell acute lymphoblastic leukemia (B-ALL) with TET2 and TP53 mutations.
Am J Hematol
; 91(3): 354-5, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26437693
19.
HDM4 is overexpressed in mantle cell lymphoma and its inhibition induces p21 expression and apoptosis.
Mod Pathol
; 23(3): 381-91, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20062013
20.
Acute myeloid leukemia harboring t(8;21)(q22;q22): a heterogeneous disease with poor outcome in a subset of patients unrelated to secondary cytogenetic aberrations.
Mod Pathol
; 21(8): 1029-36, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18536654